OK…that is smart…
So what is the problem, then, I wonder?
how persuasive is the person in charge of recruitment? Why are parents of eligible subjects saying no?
Fancy embarking on a clinical trial where you expect recruitment to take 6 years!!!! (I am referring to Neuren's competitor, not Neuren…although we never know….maybe in five years' time, we may be still asking “why hasn’t the Angelman trial finished recruiting?”
…
The market seems to have lost patience with NEU at the moment.
maybe Trevor Scott was sending us all a message: “Nothing happening in NEU for a while, folks…perhaps you should consider following me out the door at $13 with at least some of your shares”.
oh, well…
Ann: Neuren commences Phase 2 trial of NNZ-2591 in Angelman, page-25
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.03 |
Change
0.700(4.29%) |
Mkt cap ! $2.176B | |||
| Open | High | Low | Value | Volume |
| $16.49 | $17.21 | $16.44 | $11.40M | 677.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4624 | $17.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.05 | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |